Concepedia
Statistics
Publications
2
Citations
183
H-Index
Active since
2010
Affiliations
Boehringer Ingelheim (Germany)(Current)
Institut für Klinische Forschung und Entwicklung
B. Uhlig‐Laske is an author at Boehringer Ingelheim (Germany).
Publications per year
2010–2011
Linagliptin (BI 1356), a potent and selective DPP‐4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes
Thomas Först, B. Uhlig‐Laske, Arne Ring et al. · Diabetic Medicine · 2010 · 128 citations
The oral DPP‐4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus
Thomas Först, B. Uhlig‐Laske, Arne Ring et al. · Diabetes Obesity and Metabolism · 2011 · 55 citations
1–2 of 2